The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pomalidomide Market Research Report 2025
Synopsis
The global Pomalidomide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Pomalidomide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pomalidomide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pomalidomide include Celgene, Natco Pharma, Intas Pharmaceuticals, Indiabulls Pharmaceutical, Cipla, Glenmark Pharmaceuticals, Dr Reddy's Laboratories, Qilu Pharmaceutical and Chia Tai-Tianqing, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pomalidomide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pomalidomide.
Report Scope
The Pomalidomide market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pomalidomide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pomalidomide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Celgene
Natco Pharma
Intas Pharmaceuticals
Indiabulls Pharmaceutical
Cipla
Glenmark Pharmaceuticals
Dr Reddy's Laboratories
Qilu Pharmaceutical
Chia Tai-Tianqing
Hanson Pharm
Meidakang Huakang Pharmaceutical
Shandong Kongfu Pharmaceutical
SL PHARM
Segment by Type
1mg Tables
2mg Tables
4mg Tables
Segment by Application
Hospital
Drug Center
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pomalidomide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pomalidomide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Pomalidomide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Pomalidomide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pomalidomide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pomalidomide include Celgene, Natco Pharma, Intas Pharmaceuticals, Indiabulls Pharmaceutical, Cipla, Glenmark Pharmaceuticals, Dr Reddy's Laboratories, Qilu Pharmaceutical and Chia Tai-Tianqing, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pomalidomide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pomalidomide.
Report Scope
The Pomalidomide market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pomalidomide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pomalidomide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Celgene
Natco Pharma
Intas Pharmaceuticals
Indiabulls Pharmaceutical
Cipla
Glenmark Pharmaceuticals
Dr Reddy's Laboratories
Qilu Pharmaceutical
Chia Tai-Tianqing
Hanson Pharm
Meidakang Huakang Pharmaceutical
Shandong Kongfu Pharmaceutical
SL PHARM
Segment by Type
1mg Tables
2mg Tables
4mg Tables
Segment by Application
Hospital
Drug Center
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pomalidomide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pomalidomide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pomalidomide Market Overview
1.1 Product Overview and Scope of Pomalidomide
1.2 Pomalidomide Segment by Type
1.2.1 Global Pomalidomide Market Value Comparison by Type (2024-2030)
1.2.2 1mg Tables
1.2.3 2mg Tables
1.2.4 4mg Tables
1.3 Pomalidomide Segment by Application
1.3.1 Global Pomalidomide Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Center
1.3.4 Clinic
1.3.5 Others
1.4 Global Pomalidomide Market Size Estimates and Forecasts
1.4.1 Global Pomalidomide Revenue 2019-2030
1.4.2 Global Pomalidomide Sales 2019-2030
1.4.3 Global Pomalidomide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pomalidomide Market Competition by Manufacturers
2.1 Global Pomalidomide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pomalidomide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pomalidomide Average Price by Manufacturers (2019-2024)
2.4 Global Pomalidomide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pomalidomide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pomalidomide, Product Type & Application
2.7 Pomalidomide Market Competitive Situation and Trends
2.7.1 Pomalidomide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pomalidomide Players Market Share by Revenue
2.7.3 Global Pomalidomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pomalidomide Retrospective Market Scenario by Region
3.1 Global Pomalidomide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pomalidomide Global Pomalidomide Sales by Region: 2019-2030
3.2.1 Global Pomalidomide Sales by Region: 2019-2024
3.2.2 Global Pomalidomide Sales by Region: 2025-2030
3.3 Global Pomalidomide Global Pomalidomide Revenue by Region: 2019-2030
3.3.1 Global Pomalidomide Revenue by Region: 2019-2024
3.3.2 Global Pomalidomide Revenue by Region: 2025-2030
3.4 North America Pomalidomide Market Facts & Figures by Country
3.4.1 North America Pomalidomide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pomalidomide Sales by Country (2019-2030)
3.4.3 North America Pomalidomide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pomalidomide Market Facts & Figures by Country
3.5.1 Europe Pomalidomide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pomalidomide Sales by Country (2019-2030)
3.5.3 Europe Pomalidomide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pomalidomide Market Facts & Figures by Country
3.6.1 Asia Pacific Pomalidomide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pomalidomide Sales by Country (2019-2030)
3.6.3 Asia Pacific Pomalidomide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pomalidomide Market Facts & Figures by Country
3.7.1 Latin America Pomalidomide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pomalidomide Sales by Country (2019-2030)
3.7.3 Latin America Pomalidomide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pomalidomide Market Facts & Figures by Country
3.8.1 Middle East and Africa Pomalidomide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pomalidomide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pomalidomide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pomalidomide Sales by Type (2019-2030)
4.1.1 Global Pomalidomide Sales by Type (2019-2024)
4.1.2 Global Pomalidomide Sales by Type (2025-2030)
4.1.3 Global Pomalidomide Sales Market Share by Type (2019-2030)
4.2 Global Pomalidomide Revenue by Type (2019-2030)
4.2.1 Global Pomalidomide Revenue by Type (2019-2024)
4.2.2 Global Pomalidomide Revenue by Type (2025-2030)
4.2.3 Global Pomalidomide Revenue Market Share by Type (2019-2030)
4.3 Global Pomalidomide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pomalidomide Sales by Application (2019-2030)
5.1.1 Global Pomalidomide Sales by Application (2019-2024)
5.1.2 Global Pomalidomide Sales by Application (2025-2030)
5.1.3 Global Pomalidomide Sales Market Share by Application (2019-2030)
5.2 Global Pomalidomide Revenue by Application (2019-2030)
5.2.1 Global Pomalidomide Revenue by Application (2019-2024)
5.2.2 Global Pomalidomide Revenue by Application (2025-2030)
5.2.3 Global Pomalidomide Revenue Market Share by Application (2019-2030)
5.3 Global Pomalidomide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Celgene
6.1.1 Celgene Corporation Information
6.1.2 Celgene Description and Business Overview
6.1.3 Celgene Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Celgene Pomalidomide Product Portfolio
6.1.5 Celgene Recent Developments/Updates
6.2 Natco Pharma
6.2.1 Natco Pharma Corporation Information
6.2.2 Natco Pharma Description and Business Overview
6.2.3 Natco Pharma Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Natco Pharma Pomalidomide Product Portfolio
6.2.5 Natco Pharma Recent Developments/Updates
6.3 Intas Pharmaceuticals
6.3.1 Intas Pharmaceuticals Corporation Information
6.3.2 Intas Pharmaceuticals Description and Business Overview
6.3.3 Intas Pharmaceuticals Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Intas Pharmaceuticals Pomalidomide Product Portfolio
6.3.5 Intas Pharmaceuticals Recent Developments/Updates
6.4 Indiabulls Pharmaceutical
6.4.1 Indiabulls Pharmaceutical Corporation Information
6.4.2 Indiabulls Pharmaceutical Description and Business Overview
6.4.3 Indiabulls Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Indiabulls Pharmaceutical Pomalidomide Product Portfolio
6.4.5 Indiabulls Pharmaceutical Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipla Pomalidomide Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Glenmark Pharmaceuticals
6.6.1 Glenmark Pharmaceuticals Corporation Information
6.6.2 Glenmark Pharmaceuticals Description and Business Overview
6.6.3 Glenmark Pharmaceuticals Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Glenmark Pharmaceuticals Pomalidomide Product Portfolio
6.6.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.7 Dr Reddy's Laboratories
6.6.1 Dr Reddy's Laboratories Corporation Information
6.6.2 Dr Reddy's Laboratories Description and Business Overview
6.6.3 Dr Reddy's Laboratories Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dr Reddy's Laboratories Pomalidomide Product Portfolio
6.7.5 Dr Reddy's Laboratories Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Corporation Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qilu Pharmaceutical Pomalidomide Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Chia Tai-Tianqing
6.9.1 Chia Tai-Tianqing Corporation Information
6.9.2 Chia Tai-Tianqing Description and Business Overview
6.9.3 Chia Tai-Tianqing Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Chia Tai-Tianqing Pomalidomide Product Portfolio
6.9.5 Chia Tai-Tianqing Recent Developments/Updates
6.10 Hanson Pharm
6.10.1 Hanson Pharm Corporation Information
6.10.2 Hanson Pharm Description and Business Overview
6.10.3 Hanson Pharm Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hanson Pharm Pomalidomide Product Portfolio
6.10.5 Hanson Pharm Recent Developments/Updates
6.11 Meidakang Huakang Pharmaceutical
6.11.1 Meidakang Huakang Pharmaceutical Corporation Information
6.11.2 Meidakang Huakang Pharmaceutical Pomalidomide Description and Business Overview
6.11.3 Meidakang Huakang Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Meidakang Huakang Pharmaceutical Pomalidomide Product Portfolio
6.11.5 Meidakang Huakang Pharmaceutical Recent Developments/Updates
6.12 Shandong Kongfu Pharmaceutical
6.12.1 Shandong Kongfu Pharmaceutical Corporation Information
6.12.2 Shandong Kongfu Pharmaceutical Pomalidomide Description and Business Overview
6.12.3 Shandong Kongfu Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shandong Kongfu Pharmaceutical Pomalidomide Product Portfolio
6.12.5 Shandong Kongfu Pharmaceutical Recent Developments/Updates
6.13 SL PHARM
6.13.1 SL PHARM Corporation Information
6.13.2 SL PHARM Pomalidomide Description and Business Overview
6.13.3 SL PHARM Pomalidomide Sales, Revenue and Gross Margin (2019-2024)
6.13.4 SL PHARM Pomalidomide Product Portfolio
6.13.5 SL PHARM Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pomalidomide Industry Chain Analysis
7.2 Pomalidomide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pomalidomide Production Mode & Process
7.4 Pomalidomide Sales and Marketing
7.4.1 Pomalidomide Sales Channels
7.4.2 Pomalidomide Distributors
7.5 Pomalidomide Customers
8 Pomalidomide Market Dynamics
8.1 Pomalidomide Industry Trends
8.2 Pomalidomide Market Drivers
8.3 Pomalidomide Market Challenges
8.4 Pomalidomide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pomalidomide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pomalidomide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pomalidomide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pomalidomide Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Pomalidomide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pomalidomide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pomalidomide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pomalidomide Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pomalidomide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pomalidomide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pomalidomide, Product Type & Application
Table 12. Global Key Manufacturers of Pomalidomide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pomalidomide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pomalidomide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pomalidomide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pomalidomide Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Pomalidomide Sales Market Share by Region (2019-2024)
Table 19. Global Pomalidomide Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Pomalidomide Sales Market Share by Region (2025-2030)
Table 21. Global Pomalidomide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pomalidomide Revenue Market Share by Region (2019-2024)
Table 23. Global Pomalidomide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pomalidomide Revenue Market Share by Region (2025-2030)
Table 25. North America Pomalidomide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pomalidomide Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Pomalidomide Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Pomalidomide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pomalidomide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pomalidomide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pomalidomide Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Pomalidomide Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Pomalidomide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pomalidomide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pomalidomide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pomalidomide Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Pomalidomide Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Pomalidomide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pomalidomide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pomalidomide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pomalidomide Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Pomalidomide Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Pomalidomide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pomalidomide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pomalidomide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pomalidomide Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Pomalidomide Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Pomalidomide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pomalidomide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pomalidomide Sales (K Pcs) by Type (2019-2024)
Table 51. Global Pomalidomide Sales (K Pcs) by Type (2025-2030)
Table 52. Global Pomalidomide Sales Market Share by Type (2019-2024)
Table 53. Global Pomalidomide Sales Market Share by Type (2025-2030)
Table 54. Global Pomalidomide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pomalidomide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pomalidomide Revenue Market Share by Type (2019-2024)
Table 57. Global Pomalidomide Revenue Market Share by Type (2025-2030)
Table 58. Global Pomalidomide Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Pomalidomide Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Pomalidomide Sales (K Pcs) by Application (2019-2024)
Table 61. Global Pomalidomide Sales (K Pcs) by Application (2025-2030)
Table 62. Global Pomalidomide Sales Market Share by Application (2019-2024)
Table 63. Global Pomalidomide Sales Market Share by Application (2025-2030)
Table 64. Global Pomalidomide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pomalidomide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pomalidomide Revenue Market Share by Application (2019-2024)
Table 67. Global Pomalidomide Revenue Market Share by Application (2025-2030)
Table 68. Global Pomalidomide Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Pomalidomide Price (USD/Pcs) by Application (2025-2030)
Table 70. Celgene Corporation Information
Table 71. Celgene Description and Business Overview
Table 72. Celgene Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Celgene Pomalidomide Product
Table 74. Celgene Recent Developments/Updates
Table 75. Natco Pharma Corporation Information
Table 76. Natco Pharma Description and Business Overview
Table 77. Natco Pharma Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Natco Pharma Pomalidomide Product
Table 79. Natco Pharma Recent Developments/Updates
Table 80. Intas Pharmaceuticals Corporation Information
Table 81. Intas Pharmaceuticals Description and Business Overview
Table 82. Intas Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Intas Pharmaceuticals Pomalidomide Product
Table 84. Intas Pharmaceuticals Recent Developments/Updates
Table 85. Indiabulls Pharmaceutical Corporation Information
Table 86. Indiabulls Pharmaceutical Description and Business Overview
Table 87. Indiabulls Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Indiabulls Pharmaceutical Pomalidomide Product
Table 89. Indiabulls Pharmaceutical Recent Developments/Updates
Table 90. Cipla Corporation Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. Cipla Pomalidomide Product
Table 94. Cipla Recent Developments/Updates
Table 95. Glenmark Pharmaceuticals Corporation Information
Table 96. Glenmark Pharmaceuticals Description and Business Overview
Table 97. Glenmark Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Glenmark Pharmaceuticals Pomalidomide Product
Table 99. Glenmark Pharmaceuticals Recent Developments/Updates
Table 100. Dr Reddy's Laboratories Corporation Information
Table 101. Dr Reddy's Laboratories Description and Business Overview
Table 102. Dr Reddy's Laboratories Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Dr Reddy's Laboratories Pomalidomide Product
Table 104. Dr Reddy's Laboratories Recent Developments/Updates
Table 105. Qilu Pharmaceutical Corporation Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. Qilu Pharmaceutical Pomalidomide Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Chia Tai-Tianqing Corporation Information
Table 111. Chia Tai-Tianqing Description and Business Overview
Table 112. Chia Tai-Tianqing Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. Chia Tai-Tianqing Pomalidomide Product
Table 114. Chia Tai-Tianqing Recent Developments/Updates
Table 115. Hanson Pharm Corporation Information
Table 116. Hanson Pharm Description and Business Overview
Table 117. Hanson Pharm Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. Hanson Pharm Pomalidomide Product
Table 119. Hanson Pharm Recent Developments/Updates
Table 120. Meidakang Huakang Pharmaceutical Corporation Information
Table 121. Meidakang Huakang Pharmaceutical Description and Business Overview
Table 122. Meidakang Huakang Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Meidakang Huakang Pharmaceutical Pomalidomide Product
Table 124. Meidakang Huakang Pharmaceutical Recent Developments/Updates
Table 125. Shandong Kongfu Pharmaceutical Corporation Information
Table 126. Shandong Kongfu Pharmaceutical Description and Business Overview
Table 127. Shandong Kongfu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 128. Shandong Kongfu Pharmaceutical Pomalidomide Product
Table 129. Shandong Kongfu Pharmaceutical Recent Developments/Updates
Table 130. SL PHARM Corporation Information
Table 131. SL PHARM Description and Business Overview
Table 132. SL PHARM Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 133. SL PHARM Pomalidomide Product
Table 134. SL PHARM Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Pomalidomide Distributors List
Table 138. Pomalidomide Customers List
Table 139. Pomalidomide Market Trends
Table 140. Pomalidomide Market Drivers
Table 141. Pomalidomide Market Challenges
Table 142. Pomalidomide Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pomalidomide
Figure 2. Global Pomalidomide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pomalidomide Market Share by Type in 2023 & 2030
Figure 4. 1mg Tables Product Picture
Figure 5. 2mg Tables Product Picture
Figure 6. 4mg Tables Product Picture
Figure 7. Global Pomalidomide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Pomalidomide Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Drug Center
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Pomalidomide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pomalidomide Market Size (2019-2030) & (US$ Million)
Figure 15. Global Pomalidomide Sales (2019-2030) & (K Pcs)
Figure 16. Global Pomalidomide Average Price (USD/Pcs) & (2019-2030)
Figure 17. Pomalidomide Report Years Considered
Figure 18. Pomalidomide Sales Share by Manufacturers in 2023
Figure 19. Global Pomalidomide Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Pomalidomide Players: Market Share by Revenue in 2023
Figure 21. Pomalidomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Pomalidomide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Pomalidomide Sales Market Share by Country (2019-2030)
Figure 24. North America Pomalidomide Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Pomalidomide Sales Market Share by Country (2019-2030)
Figure 28. Europe Pomalidomide Revenue Market Share by Country (2019-2030)
Figure 29. Germany Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Pomalidomide Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Pomalidomide Revenue Market Share by Region (2019-2030)
Figure 36. China Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Pomalidomide Sales Market Share by Country (2019-2030)
Figure 47. Latin America Pomalidomide Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Pomalidomide Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Pomalidomide Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Pomalidomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Pomalidomide by Type (2019-2030)
Figure 57. Global Revenue Market Share of Pomalidomide by Type (2019-2030)
Figure 58. Global Pomalidomide Price (USD/Pcs) by Type (2019-2030)
Figure 59. Global Sales Market Share of Pomalidomide by Application (2019-2030)
Figure 60. Global Revenue Market Share of Pomalidomide by Application (2019-2030)
Figure 61. Global Pomalidomide Price (USD/Pcs) by Application (2019-2030)
Figure 62. Pomalidomide Value Chain
Figure 63. Pomalidomide Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
